Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomas
about
Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens.Qualitative and quantitative promoter hypermethylation patterns of the P16, TSHR, RASSF1A and RARβ2 genes in papillary thyroid carcinoma.p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease.Cyclooxygenase 2-dependent and independent activation of Akt through casein kinase 2α contributes to human bladder cancer cell survival.Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway.Dynamics of ARF regulation that control senescence and cancer.ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladderEpigenetic changes in prostate cancer: implication for diagnosis and treatment.Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.PTEN deficiency mediates a reciprocal response to IGFI and mTOR inhibition.Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancerPromoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma.Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer.Molecular pathology of prostate cancer.Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancerTherapeutic targets in the ARF tumor suppressor pathway.Targeting prostate cancer based on signal transduction and cell cycle pathways.Tumor dormancy of primary and secondary cancers.The ARF tumor suppressor: structure, functions and status in cancer.Promoter hypermethylation in prostate cancer.Genomic Rearrangements of PTEN in Prostate Cancer.ETV1 positively regulates transcription of tumor suppressor ARF.Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells.Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma.Syndecan-1, a new target molecule involved in progression of androgen-independent prostate cancer.Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells.Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer.c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas.Phosphorylation status of Fas-associated death domain-containing protein (FADD) is associated with prostate cancer progression.Identifying aggressive prostate cancer foci using a DNA methylation classifier.DNA methylation in promoter region as biomarkers in prostate cancer.Immunohistochemical analysis of inflammatory cells in benign and precancerous lesions and carcinoma of the prostate.DNA hypermethylation status of multiple genes in prostate adenocarcinomas.Regulatory Network of ARF in Cancer Development.Genetic mapping of allelic loss on chromosome 6q within heterogeneous prostate carcinoma.Aberrant p16INK4A RNA transcripts expressed in hepatocellular carcinoma cell lines regulate pRb phosphorylation by binding with CDK4, resulting in delayed cell cycle progression.PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications
P2860
Q33202648-1B10B9F6-7F00-4EE8-8A9E-326DEC4857EAQ33599822-23F29855-423A-4E54-971F-BB345FE6422CQ33882580-735FB5B8-19B1-4631-B7F3-8B033FFACA96Q33904650-067C62A2-6CEC-4C0C-85A9-190790E48284Q33926909-6A7A0C49-1D01-4867-BFDC-96BAAD21EA01Q34047232-EB39679D-69AF-4B96-ABF5-2BE90208FB76Q34059983-3D16E0ED-1A17-41C3-A57D-2D1CD6C64EA4Q34385658-691BE66E-EC08-45F3-8C2E-83968B954032Q34482050-049438D5-F6E7-4A27-BE65-052E8A6937F2Q34518277-676A69B3-E362-45C1-BF3E-2BE1714011F7Q34667906-FB38E060-5E32-4793-8B2A-26CF12EAF40FQ35789796-3B73E656-1535-4CCB-A35E-2E43B0436582Q35854235-565A9012-4367-4843-95C7-4E98AF0E18A4Q36249264-391AD8CB-9F4E-4D0D-9CFB-6C0CF51A3CC8Q36787663-9C686822-7873-42E6-864B-934F396705B4Q36879301-99583177-89BD-4756-9354-6084D2D1AAD4Q36995054-8359D5AD-233A-451A-A5A8-55EBA13829E4Q37286241-93FE54D8-DC4F-490E-A524-AF161FB434ECQ37765233-1E2537FA-835A-428D-B5E6-E1F95B9C8196Q37791396-23A9D36B-584D-442C-A36A-1A711EE80948Q38142173-D31BFF99-0025-490D-94CE-37212C918418Q39071032-F703C11C-3ABF-466E-AACC-06DBCE04D477Q39755221-74F0C796-87CB-46BC-B097-DA805D3CF4C8Q39782934-71204AB2-2338-4B56-B83D-C842AE5CF301Q39853186-1467F610-CB92-4CE9-882E-9BE7EE030758Q39956460-C83573B1-51DD-44DF-BC7F-B6D1F756DBFEQ40059974-0764A8AB-EFCC-4E24-8B59-422D5B82CA19Q40095771-877CEF34-732A-4FB3-9E2B-0DC2C7CC6838Q40419581-AF47F6BB-91E5-4B13-B5CC-719947DCD439Q42090895-9D28115B-4ABB-4258-A743-F0C82DAA8370Q42261678-ADA0271F-7C44-417C-B81B-92A135DCA0F5Q43555348-43A50EB5-14F2-4853-AAEB-A674FC451FA8Q44083581-5947B2F6-FF8D-4088-B5B4-A1039C40CEE3Q52582577-D562F4BB-FA98-4735-A390-CDC4747C523CQ53376016-3D46AC76-A984-40D8-A4CE-12A656A423A3Q53651249-D9B9521C-AA6E-46E6-B564-509D9F2A5574Q57790325-47B7EE99-8425-47AC-9880-C3DEE935F764
P2860
Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomas
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Heterogeneous methylation and ...... cus within prostate carcinomas
@en
Heterogeneous methylation and ...... cus within prostate carcinomas
@nl
type
label
Heterogeneous methylation and ...... cus within prostate carcinomas
@en
Heterogeneous methylation and ...... cus within prostate carcinomas
@nl
prefLabel
Heterogeneous methylation and ...... cus within prostate carcinomas
@en
Heterogeneous methylation and ...... cus within prostate carcinomas
@nl
P2093
P2860
P1476
Heterogeneous methylation and ...... cus within prostate carcinomas
@en
P2093
Eiwa Ishida
Keiji Shimada
Masayoshi Nishimine
Mitsutoshi Nakamura
Munehiro Kishi
Noboru Konishi
P2860
P304
P356
10.1016/S0002-9440(10)62547-3
P407
P577
2002-04-01T00:00:00Z